Comparison of Ocular Changes by Surgical Menopause Using Optical Coherence Tomography (OCT)

June 17, 2023 updated by: Erhan Okuyan,M.D, Batman Training and Research Hospital

The aim of this study is to investigate the early changes in macular thickness, corneal thickness and intraocular pressure in young women undergoing surgical menopause.

Methods: Eye findings of 30 surgical menopausal (Postoperative 3-6 months) and 48 natural menopause and 22 healty women (control) were evaluated using OCT. Women with no known eye disease, no chronic disease (Diabetes Mellitus, Cardiac Disease any Autoimmune disease) and no migraine in addition to non smokers were included in the study. Women using any hormone and obese women ( BMI >25 kg/m2) were excluded. Macular and corneal thickness and intraocular pressure (IOP) were measured in both eyes of the women

Study Overview

Detailed Description

This prospective case control study was conducted in a tertiary gynecology and obstetrics clinic and eye clinic between 2020 and 2021 with ethics committee approval number 2020 250 ). Informed consent form was obtained from all participants. All participants were outpatients who applied to obstetrics clinic in Batman Training and Research Hospital.

The study started with 105 patient. Based on the study exclusion criteria, 7 patients were excluded from the study. Every patient in the surgical menopause group underwent a hysterectomy and bilateral salpingo-oophorectomy for benign uterine reasons. The patients included in the study were menstruating women with preoperative natural ovarian appearance and benign non ovarian indications, who had undergone hysterectomy and bilateral salpingo-oophorectomy and had no preoperative menopause complaints. Patients younger than 52 years of age who have undergone oophorectomy are patients whose ovaries have been removed either because of patient anxiety due to a family history of cancer or because of adhesions.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Batman, Turkey, 72100
        • Batman education adn research hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patient selection was made between surgical menopause, natural menopause and healthy women who have given birth before.

Description

Inclusion Criteria:

  • The patients included in the study were menstruating women with preoperative natural ovarian appearance and benign non ovarian indications, who had undergone hysterectomy and bilateral salpingo-oopherectomy, and had no preoperative menopause complaints. Patients younger than 52 years of age who have undergone oophorectomy are patients whose ovaries have been removed either because of patient anxiety due to a family history of cancer or because of adhesions.
  • having a healthy child
  • have consented to participate in the study

Exclusion Criteria:

  • Chronic disease (such as diabetes, heart disease)
  • History of continuous drug use
  • Unwillingness to participate in the study Being between the ages of 18-30

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1( Surgical menopause)
Surgical menopause : At least 6 months after hysterectomy and salphingo-oopherectomy
Eye examination of patients with optic coherence tomography test by an ophthalmologist
2 ( Natural menopause )
Natural menopause :Healthy female patients who have not had a menstrual period for at least 1 year and have not received any treatment for this reason before
Eye examination of patients with optic coherence tomography test by an ophthalmologist
3 (Control )
Healthy women aged 30-45 years with regular menstrual cycles and no symptoms of menopause
Eye examination of patients with optic coherence tomography test by an ophthalmologist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of surgical menopause on corneal and macular thickness
Time Frame: 6 months after hysterectomy and bilateral salpingo-oopherectomy
To question the effect on macular and corneal thickness secondary to sudden ovarian hormone change with surgical menopause.
6 months after hysterectomy and bilateral salpingo-oopherectomy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eye examination needed after surgical menopause
Time Frame: 6-12 months
To seek an answer to the question of adding eye diseases examination to the examinations of post-surgical menopause patients.
6-12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erhan Okuyan, Batman Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2022

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

June 17, 2023

First Submitted That Met QC Criteria

June 17, 2023

First Posted (Actual)

June 27, 2023

Study Record Updates

Last Update Posted (Actual)

June 27, 2023

Last Update Submitted That Met QC Criteria

June 17, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023 (Other Grant/Funding Number: GRAMMY Museum Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Will be given to the journal upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Corneal Deformity

Clinical Trials on Optic coherence tomography

3
Subscribe